Literature DB >> 11147259

Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.

R O Estacio1, R W Schrier.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11147259

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN： 0065-2822


× No keyword cloud information.
  12 in total

Review 1.  What should we measure in the diabetic patient and how does this respond to therapy?

Authors:  Desmond G Johnston; Stephen Robinson; Shareen Forbes
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Authors:  K O Alsaad; A M Herzenberg
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

3.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

Authors:  Markus Gödel; Björn Hartleben; Nadja Herbach; Shuya Liu; Stefan Zschiedrich; Shun Lu; Andrea Debreczeni-Mór; Maja T Lindenmeyer; Maria-Pia Rastaldi; Götz Hartleben; Thorsten Wiech; Alessia Fornoni; Robert G Nelson; Matthias Kretzler; Rüdiger Wanke; Hermann Pavenstädt; Dontscho Kerjaschki; Clemens D Cohen; Michael N Hall; Markus A Rüegg; Ken Inoki; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

Review 4.  Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.

Authors:  Avileen Kaur; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2017-04-17       Impact factor: 4.473

5.  Erk in kidney diseases.

Authors:  Denis Feliers; Balakuntalam S Kasinath
Journal:  J Signal Transduct       Date:  2011-04-07

6.  Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.

Authors:  Eunjin Sohn; Junghyun Kim; Chan Sik Kim; Kyuhyung Jo; Jin Sook Kim
Journal:  Mol Med Rep       Date:  2015-08-11       Impact factor: 2.952

7.  Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.

Authors:  Xinxing Lu; Qiuling Fan; Li Xu; Lin Li; Yuan Yue; Yanyan Xu; Yan Su; Dongcheng Zhang; Lining Wang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

8.  The Extract of Litsea japonica Reduced the Development of Diabetic Nephropathy via the Inhibition of Advanced Glycation End Products Accumulation in db/db Mice.

Authors:  Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Kyuhyung Jo; So Dam Shin; Joo Hwan Kim; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-27       Impact factor: 2.629

Review 9.  Diabetes mellitus in the transplanted kidney.

Authors:  Vasil Peev; Jochen Reiser; Nada Alachkar
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-27       Impact factor: 5.555

Review 10.  Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus.

Authors:  P Anil Kumar; Gavin I Welsh; Moin A Saleem; Ram K Menon
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-25       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.